🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Philadelphia, PA

34 pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Philadelphia (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2
  • Thomas Jefferson University Hospital, Philadelphia
Edad 60 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07437950

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Nagre-recruitPhase 1
  • Children's Hospital of Philadelphia, Philadelphia
Hanggang edad 21 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07012044

Assessment of Geriatric Evaluations Impact on New AML Guidance

Nagre-recruitObservasyonal na pag-aaral
  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
Edad 50 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05909501

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral
  • Children's Hospital of Philadelphia, Philadelphia
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3
  • Thomas Jefferson University, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2
  • Thomas Jefferson University Hospital, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Nagre-recruitPhase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo
6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Nagre-recruitPhase 1/2
  • University of Pennsylvania, Philadelphia
30 Days · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04065399

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Nagre-recruitPhase 1
  • UPENN Perelman Center for Advanced Medicine, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06846606

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Nagre-recruitPhase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours Alfred I. Dupont Hospital for Children, Wilmington · 25 mi ang layo
29 Days – 21 Years · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3
  • University of Pennsylvania, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Nagre-recruitPhase 2/3
  • University of Pennsylvania, Philadelphia
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06788756

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Nagre-recruitPhase 1
  • Children's Hospital of Philadelphia, Philadelphia
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06177067

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

Nagre-recruitPhase 2
  • Penn Medicine Abramson Cancer Center, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05442216

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

Nagre-recruitPhase 1
  • University of Pennsylvania, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT05945849

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Nagre-recruit
  • Children's Hospital of Philadelphia, Philadelphia
Hanggang edad 25 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT03810196

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1
  • Children's Hospital of Philadelphia, Philadelphia
Edad 0 hanggang 29 · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07464951

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Nagre-recruitPhase 1/2
  • Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT04068597

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

Nagre-recruitPhase 1
  • University of Pennsylvania, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT06222580

Massage Impact on Sleep in Pediatric Oncology

Nagre-recruit
  • Children's Hospital of Philadelphia, Philadelphia
Edad 12 hanggang 21 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06892158

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Nagre-recruitPhase 1/2
  • Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

Nagre-recruitPhase 1/2
  • University of Pennsylvania, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT04990102

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Nagre-recruitPhase 1
  • Thomas Jefferson University Hospital, Philadelphia
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT06994676

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1
  • Hospital of the University of Pennsylvania, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Tazemetostat and Palbociclib With CPX-351for R/R AML

Nagre-recruitPhase 1
  • Thomas Jefferson University Hospital, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT05627232

Home Blood Transfusions

Nagre-recruit
  • Thomas Jefferson University Hospital, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT07121140

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • University of Pennsylvania, Philadelphia
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Hul 25, 2025 · NCT05237258

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.